The 60.3% recurrence rate after stopping suggests ongoing treatment is needed, but long-term safety data for this specific population does not exist
Judge Beth Bloom in a Miami court in the Southern District of Florida issued a permanent injunction against Ekzotika Corporation, ordering it to stop using Novos trademarks for any purpose including advertising, or insinuating that any of its compounded drugs are authentic, contain genuine semaglutide or are approved by the FDA
Presented for research literature review only Aivaliotis MJ et al
If you would like more information, talk with your healthcare provider
A quick analogy to make this stick: brand names are like different manuals for the same engine, and ignoring the manual you actually have in hand guarantees more unnecessary repairs than tuning
GLP-1 also sends a second message to the pancreas at the same time: it tells the pancreas to stop releasing glucagon the hormone that raises blood sugar